GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Amcad Biomed Corp (ROCO:4188) » Definitions » Shiller PE Ratio

Amcad Biomed (ROCO:4188) Shiller PE Ratio : (As of May. 20, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Amcad Biomed Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Amcad Biomed Shiller PE Ratio Historical Data

The historical data trend for Amcad Biomed's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amcad Biomed Shiller PE Ratio Chart

Amcad Biomed Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Amcad Biomed Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Amcad Biomed's Shiller PE Ratio

For the Medical Devices subindustry, Amcad Biomed's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amcad Biomed's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Amcad Biomed's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Amcad Biomed's Shiller PE Ratio falls into.



Amcad Biomed Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Amcad Biomed's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Amcad Biomed's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.29/131.7762*131.7762
=-0.290

Current CPI (Mar. 2024) = 131.7762.

Amcad Biomed Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.234 100.560 -0.307
201409 -0.369 100.428 -0.484
201412 -0.369 99.070 -0.491
201503 -0.514 99.621 -0.680
201506 -0.320 100.684 -0.419
201509 -0.360 100.392 -0.473
201512 -0.390 99.792 -0.515
201603 -0.370 100.470 -0.485
201606 -0.360 101.688 -0.467
201609 -0.260 101.861 -0.336
201612 -0.237 101.863 -0.307
201703 -0.270 102.862 -0.346
201706 -0.270 103.349 -0.344
201709 -0.240 104.136 -0.304
201712 -0.330 104.011 -0.418
201803 0.010 105.290 0.013
201806 -0.190 106.317 -0.235
201809 -0.350 106.507 -0.433
201812 -0.320 105.998 -0.398
201903 -0.110 107.251 -0.135
201906 -0.030 108.070 -0.037
201909 -0.230 108.329 -0.280
201912 -0.342 108.420 -0.416
202003 -0.300 108.902 -0.363
202006 -0.100 108.767 -0.121
202009 -0.190 109.815 -0.228
202012 -0.081 109.897 -0.097
202103 -0.210 111.754 -0.248
202106 -0.160 114.631 -0.184
202109 0.001 115.734 0.001
202112 -0.120 117.630 -0.134
202203 -0.150 121.301 -0.163
202206 -0.220 125.017 -0.232
202209 -0.270 125.227 -0.284
202212 -0.380 125.222 -0.400
202303 -0.200 127.348 -0.207
202306 -0.240 128.729 -0.246
202309 -0.200 129.860 -0.203
202312 -0.205 129.419 -0.209
202403 -0.290 131.776 -0.290

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Amcad Biomed  (ROCO:4188) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Amcad Biomed Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Amcad Biomed's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Amcad Biomed (ROCO:4188) Business Description

Traded in Other Exchanges
N/A
Address
No. 167, Fuxing North Road, 5th Floor, Zhongshan District, Taipei, TWN, 104
Amcad Biomed Corp develops computer-aided detection and diagnosis(CADe/CADx) software devices. Its product pipeline includes AmCAD-UT Detection, a software solution for thyroid nodules analysis; AmCAD-UV, a software device that is used for quantifying and classifying the ultrasonic color intensity data acquired from FDA-cleared ultrasound systems and displaying the noise-reduced color-coded pulsatile signals; AmCAD- U.S, a software device for viewing and quantifying ultrasound image data of backscattered signals; and AmCAD-UO offers detection for obstructive sleep apnea on awake patients to identify the root cause of sleep apnea. The company's geographical segments include Taiwan, China, and other countries, out of which the majority of the revenue is generated from China.

Amcad Biomed (ROCO:4188) Headlines

No Headlines